$12.35 $0.41 per serving
Product analysis
Memory Complex combines bacopa and ginkgo with nutrients that can support normal brain function when intake is low. The botanical preparations do not clearly match those behind the limited memory and attention findings, making extra cognitive benefits uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
Some nutrient forms and botanical components are named, but preparation quality remains uncertain for most of the formula. Missing forms and incomplete ginkgo details make direct comparison harder.
Ingredient Transparency70
All listed amounts and most forms are disclosed. Several preparations and the ginkgo composition remain incomplete.
Value For Money49
The serving cost compares favorably for bacopa and phosphorus. Value for most of the remaining formula is uncertain.
Customer Satisfaction84
Customer ratings are positive across several thousand reviews. The large review base gives a broad picture of satisfaction, without proving memory improvement.
Product Focus66
Memory and attention form a clear theme across the ingredients. Botanical findings depend on the preparation, while the vitamins mainly help when intake is low.
- Format
Tablet - Container
- 60 Tablet(s)
- Per serving
- $0.41
- Customer rating
- 4.6 · 3,615 ratings
Goals
Impact
High effect
Folate · 680 mcg DFEVitamin B6 · 2 mgVitamin B12 · 6 mcgHuperzine · 5 mcg
Folate, thiamin, niacin and vitamin B12 support concentration when low intake or deficiency interferes with normal function. More intake does not establish better focus when those needs are met. Bacopa's acute findings are limited to specific extracts, and this aerial-parts extract does not establish CDRI 08 identity. The saved findings emphasize cerebral energy supply, with smaller cholinergic and stress-related contributions rather than established immediate enhancement.
How this product is rated for Mental Focus
Ingredient fit85
Nutrients with deficiency-related roles and bacopa provide the main saved connections within a broader formula. Several declared amounts support the saved amount finding; they are not established acute enhancement doses.
Goal fit
Nutrients with deficiency-related roles and bacopa provide the main saved connections within a broader formula.
Dose adequacy
Several declared amounts support the saved amount finding; they are not established acute enhancement doses.
Pathways44
Cerebral energy supply is the strongest saved finding, with smaller cholinergic and stress-related components.
Depth
Cerebral energy supply is the strongest saved finding, with smaller cholinergic and stress-related components.
Breadth
Cerebral energy supply is the only substantially represented route.
Evidence69
Folate leads the saved evidence finding; its practical concentration benefit depends on correcting low intake or deficiency. Bacopa does not match the studied CDRI 08 preparation; the remaining qualifying ingredients receive the saved preparation finding.
Evidence strength
Folate leads the saved evidence finding; its practical concentration benefit depends on correcting low intake or deficiency.
Studied preparation
Bacopa does not match the studied CDRI 08 preparation; the remaining qualifying ingredients receive the saved preparation finding.
Formulation logic100
All five credited ingredients meet the saved amount threshold, without proving enhancement in nutrient-replete adults. No configured ingredient conflict was identified in the saved findings.
Partner coverage
The credited ingredients work alone or have their required partner in the saved findings.
Conflicts
No configured ingredient conflict was identified in the saved findings.
Effective doses
All five credited ingredients meet the saved amount threshold, without proving enhancement in nutrient-replete adults.
Huperzine Not classified
No linked studies yet.
Impact
High effect
Folate · 680 mcg DFEVitamin B12 · 6 mcgVitamin B6 · 2 mgThiamin · 1.5 mgHuperzine · 5 mcgBacopa · 300 mg
Folate, thiamin and niacin contribute to brain and nerve function when dietary intake is low. Bacopa adds a possible memory-learning connection, but its extract is not identified as one of the specific studied preparations. Although several ingredients receive recognition in the saved findings, the low amounts of B12, B6 and phosphatidylserine limit their recorded contribution, and the formula does not establish broad cognitive enhancement.
How this product is rated for Brain Health
Ingredient fit79
Credited amounts receive substantial recognition; B12, B6, huperzine and phosphatidylserine are below the saved threshold.
Goal fit
The saved focus reflects the relevant ingredients and the formula's other uses; presence alone does not establish cognitive benefit.
Dose adequacy
Credited amounts receive substantial recognition; B12, B6, huperzine and phosphatidylserine are below the saved threshold.
Pathways63
Energy metabolism is the strongest recorded area, with an oxidative-related connection also represented. Two recorded areas reach the breadth threshold, but this does not establish broad cognitive improvement.
Depth
Energy metabolism is the strongest recorded area, with an oxidative-related connection also represented.
Breadth
Two recorded areas reach the breadth threshold, but this does not establish broad cognitive improvement.
Evidence79
Folate leads the saved finding, with nutritional relevance when intake is low.
Evidence strength
Folate leads the saved finding, with nutritional relevance when intake is low.
Studied preparation
The saved preparation finding excludes Bacopa from a match to studied material; its extract identity remains unresolved.
Formulation logic100
The credited ingredients have no missing required partner or recorded conflict. Their amounts pass the saved minimum contribution rule, which does not prove clinical efficacy.
Partner coverage
No required partner is missing for the credited ingredients; this does not establish an added benefit from combining them.
Conflicts
No configured conflict was recorded; this finding does not establish the absence of all possible interactions.
Effective doses
All credited ingredients pass the saved minimum amount rule; ingredients excluded for smaller amounts are not counted in this finding.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
High effect
Thiamin · 1.5 mgVitamin B6 · 2 mgFolate · 680 mcg DFEVitamin B12 · 6 mcgHuperzine · 5 mcgBacopa · 300 mg
Bacopa has preparation-specific memory findings after repeated use, but this unidentified extract does not establish equivalence with the studied materials. Ginkgo likewise has limited acute attention-speed evidence tied to specific extracts, rather than proven long-term prevention. Thiamin, niacin and folate can help when low intake impairs cognition, without establishing extra enhancement when intake is adequate.
How this product is rated for Cognitive Support
Ingredient fit75
Vitamin B6 contributes to the saved ingredient-fit finding. The retained amounts provide partial reference coverage.
Goal fit
The retained ingredients and the product’s other active ingredients and linked uses determine how specifically the formula addresses cognition.
Dose adequacy
The retained amounts provide partial coverage of the reference comparisons; lower exposure does not imply a proportionate cognitive benefit.
Pathways60
The strongest recorded connection is oxidative and inflammatory protection. Coverage extends across multiple tracked pathways.
Depth
The strongest recorded connection is oxidative and inflammatory protection; this mapping does not establish an improvement in cognitive performance.
Breadth
Two tracked pathways reach the coverage threshold; the other tracked areas do not.
Evidence93
Vitamin B6 leads the saved evidence finding. The supplied limitations determine whether this concerns narrow tasks, selected populations or normal nutritional roles.
Evidence strength
Vitamin B6 leads the saved evidence finding; the supplied task, population and preparation limitations still restrict the cognitive benefits that can be described.
Studied preparation
Some retained ingredients do not match the preparations behind the supplied trials, limiting how directly those results apply.
Formulation logic96
No required partner was missing and no configured conflict was found. Some retained ingredients fall below the minimum amount criterion.
Partner coverage
No missing required partner was identified for the retained ingredients. This does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this does not establish overall safety or individual suitability.
Effective doses
Most retained ingredients meet the minimum amount criterion, while some fall short; the criterion does not establish clinical efficacy.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Moderate effect
Vitamin B12 · 6 mcgVitamin B12 · 6 mcgVitamin B6 · 2 mgHuperzine · 5 mcg
Ginkgo at 120 mg and bacopa at 300 mg relate mainly to memory and information processing, with bacopa findings depending on preparation and repeated use. The saved assessment does not match bacopa to the reviewed preparation. B vitamins support normal function; the small phosphatidylserine and huperzine amounts provide little added basis for a strong effect.
How this product is rated for Productivity Boost
Ingredient fit82
The relevant ingredients share the formula with ingredients directed at other needs. The assessed amounts meet the saved dose comparison.
Goal fit
The relevant ingredients share the formula with ingredients directed at other needs.
Dose adequacy
The assessed amounts meet the saved dose comparison.
Pathways17
The strongest saved connection is synaptic plasticity and neuroprotection, with limited coverage. None of the reviewed mechanisms reaches the saved level for broad coverage.
Depth
The strongest saved connection is synaptic plasticity and neuroprotection, with limited coverage.
Breadth
None of the reviewed mechanisms reaches the saved level for broad coverage.
Evidence44
Ginkgo provides the strongest saved evidence at the assessed amount, within the limits of the reviewed context. Some preparations match the reviewed evidence; Bacopa remains unmatched.
Evidence strength
Ginkgo provides the strongest saved evidence at the assessed amount, within the limits of the reviewed context.
Studied preparation
Some preparations match the reviewed evidence; Bacopa remains unmatched.
Formulation logic100
The assessed ingredients can work independently or have their relevant partner. No ingredient conflicts were recorded in the saved assessment. 3 of 3 assessed ingredients reach the saved amount threshold.
Partner coverage
The assessed ingredients can work independently or have their relevant partner.
Conflicts
No ingredient conflicts were recorded in the saved assessment.
Effective doses
3 of 3 assessed ingredients reach the saved amount threshold.
Impact
High effect
Folate · 680 mcg DFEVitamin B6 · 2 mgVitamin B12 · 6 mcg
Folate and niacin help maintain normal brain function, with mood relevance when low intake or deficiency contributes to irritability, apathy or poor concentration. Bacopa has limited, preparation-specific emotional-wellbeing findings, but this extract is not identified as the studied Bacognize preparation. Its standardization does not establish equivalent benefits. The small B6 and B12 amounts do not contribute to the saved findings.
How this product is rated for Mood Support
Ingredient fit69
The relevant declarations contribute to the saved findings, with focus and amount coverage varying by ingredient.
Goal fit
Relevant ingredients are present alongside ingredients aimed at other nutritional or health purposes.
Dose adequacy
The declared amounts provide substantial, though uneven, coverage of the saved amount references.
Pathways54
The saved findings describe potential routes related to mood, rather than demonstrated benefits across all of them.
Depth
The strongest saved connection concerns brain chemical signalling; a mechanistic connection alone does not establish improved mood.
Breadth
The saved findings are concentrated in one area rather than broad coverage of mood-related processes.
Evidence79
The evidence contribution depends on ingredient identity, preparation and the populations studied. These distinctions limit expectations for routine mood support.
Evidence strength
Vitamin B9 (Folate) provides the strongest saved evidence contribution, with benefits limited by the populations and outcomes described.
Studied preparation
The nutrient declarations are recognized, but this Bacopa extract is not established as the studied preparation.
Formulation logic100
The supplied findings identify no missing required partner or matched conflict. Amount thresholds describe the saved comparison rather than established efficacy.
Partner coverage
The included ingredients do not lack a required partner in the supplied findings; this does not demonstrate added benefit from combining them.
Conflicts
No listed ingredient conflict was matched in the supplied findings.
Effective doses
All ingredients counted here clear the saved minimum amount threshold, which is not a proven effective dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Thiamine (Thiamine Hydrochloride) | 1.5 mg | |
Vitamin B3 (Niacinamide) | 20 mg | |
Vitamin B6 (Pyridoxine Hydrochloride) | 2 mg | |
Folate | 680 mcg DFE | |
Vitamin B12 (Cyanocobalamin) | 6 mcg | |
Calcium (Dibasic Calcium Phosphate) | 192 mg | |
Phosphorus (Dibasic Calcium Phosphate) | 148 mg | |
Bacopa monnieri Aerial Parts Extract (Triterpene Glycosides) | 300 mg | |
Ginkgo biloba Leaf Extract (Ginkgo Flavone Glycosides, Terpene Lactones) | 120 mg | |
Phosphatidylserine Powder | 10 mg | |
Toothed Clubmoss Extract | 500 mcg | |
Huperzine A | 5 mcg |
Phosphorus (Dibasic Calcium Phosphate) · 148 mg OverallScore92
It provides 148 mg of phosphorus per serving, a targeted amount, at a low cost per serving. The phosphorus comes from Dicalcium Phosphate.
How this ingredient is rated
Active Ingredient Quality & Bioavailability79
Dicalcium Phosphate is the named phosphorus source.
Phosphorus Form Quality
Dicalcium Phosphate is the named phosphorus source.
Form Disclosure Clarity
The phosphorus source is named on the Supplement Facts panel.
Dose, Safety & Label Transparency100
The label states 148 mg of phosphorus per serving, a targeted amount.
Dose Adequacy and Safety
148 mg per serving falls within the stated targeted supplemental range for bone health support.
Elemental Dose Transparency
The phosphorus amount is stated as 148 mg per serving.
Value100
The cost per serving is low.
Price Per Serving Efficiency
The cost per serving is low.
120 mg of ginkgo leaf extract is stated per serving, but its value is not assessed. The extract lists 24% flavones and 6% terpenes. The ginkgolic acid level is unknown.
How this ingredient is rated
Composition and Label Disclosure70
The extract lists 24% flavones and 6% terpenes. The ginkgolic acid level is unknown.
Marker and Preparation Disclosure
The extract lists 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
The ginkgolic acid level is unknown.
Composition and Label Disclosure100
The amount and source are stated: 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
The amount and source are stated: 120 mg of ginkgo leaf extract.
Commercial Price and Usability
Value was not assessed.
Bacopa (Triterpene Glycosides) · 300 mg OverallScore33
A two-tablet serving provides 300 mg of Bacopa monnieri aerial parts extract at a low whole-product cost per serving. The bacoside percentage is unknown, so its content can't be determined.
How this ingredient is rated
Composition and Label Disclosure
No composition or quality conclusion is available in this group.
Composition and Label Disclosure0
The amount and aerial parts extract are named, but the bacoside percentage is unknown.
Amount and Label Disclosure
Bacopa monnieri aerial parts extract is named, but its bacoside percentage is unknown.
Commercial Price and Usability100
The whole-product cost per serving is low.
Commercial Price per Labeled Serving
The whole-product cost per labeled serving is low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis.
- Folate and long-chain polyunsaturated fatty acid supplementation during pregnancy has long-term effects on the attention system of 8.5-y-old offspring: a randomized controlled trial.
- Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial.
- Circulating folate concentrations and the risk of mild cognitive impairment: A prospective study on the older Chinese population without folic acid fortification.
- Normal-But-Low Serum Folate Levels and the Risks for Cognitive Impairment.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.